Literature DB >> 9006934

Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway.

A Nakao1, E Röijer, T Imamura, S Souchelnytskyi, G Stenman, C H Heldin, P ten Dijke.   

Abstract

Transforming growth factor-beta (TGF-beta) superfamily members are multifunctional cytokines that exert their effects via heteromeric complexes of two distinct serine and threonine kinase receptors. Drosophila mothers against decapentaplegic and related genes in Caenorhabditis elegans, Xenopus, and mammals were shown to function downstream in the intracellular signaling pathways of TGF-beta superfamily members. Here we report the cloning of a Mad-related protein, termed Sma- and Mad-related protein 2 (Smad2). TGF-beta stimulated the phosphorylation and nuclear translocation of Smad2 in nontransfected Mv1Lu cells. In addition, we demonstrated that TGF-beta and activin mediated phosphorylation of Smad2 after its overexpression with appropriate type I and II receptors in COS cells. Smad2 and Smad1 were found to be broadly expressed in human tissues. Smad2 is closely linked to DPC4 on chromosome 18q21.1, a region often deleted in human cancers. Cells that lack Smad2 may escape from TGF-beta-mediated growth inhibition and promote cancer progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006934     DOI: 10.1074/jbc.272.5.2896

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.

Authors:  M Bitzer; G von Gersdorff; D Liang; A Dominguez-Rosales; A A Beg; M Rojkind; E P Böttinger
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 2.  Smad linker region phosphorylation in the regulation of extracellular matrix synthesis.

Authors:  Micah L Burch; Wenhua Zheng; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2010-09-04       Impact factor: 9.261

3.  Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.

Authors:  H Lassus; R Salovaara; L A Aaltonen; R Butzow
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases.

Authors:  M P de Caestecker; W T Parks; C J Frank; P Castagnino; D P Bottaro; A B Roberts; R J Lechleider
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

5.  Transcriptional regulation of the Xlim-1 gene by activin is mediated by an element in intron I.

Authors:  M L Rebbert; I B Dawid
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

6.  TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Authors:  A Nakao; T Imamura; S Souchelnytskyi; M Kawabata; A Ishisaki; E Oeda; K Tamaki; J Hanai; C H Heldin; K Miyazono; P ten Dijke
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

7.  The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors.

Authors:  R S Lo; Y G Chen; Y Shi; N P Pavletich; J Massagué
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

8.  Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway.

Authors:  Hui Peng; Satoru Shintani; Yong Kim; David T Wong
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

9.  TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k).

Authors:  D E Montenegro; T Franklin; L C Moscinski; K S Zuckerman; X-T Hu
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

10.  The bone morphogenetic protein type Ib receptor is a major mediator of glial differentiation and cell survival in adult hippocampal progenitor cell culture.

Authors:  A Brederlau; R Faigle; M Elmi; A Zarebski; S Sjöberg; M Fujii; K Miyazono; K Funa
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.